ATE369420T1 - Kvlqt1 - im zusammenhang mit 'long qt syndrom' - Google Patents

Kvlqt1 - im zusammenhang mit 'long qt syndrom'

Info

Publication number
ATE369420T1
ATE369420T1 AT99922910T AT99922910T ATE369420T1 AT E369420 T1 ATE369420 T1 AT E369420T1 AT 99922910 T AT99922910 T AT 99922910T AT 99922910 T AT99922910 T AT 99922910T AT E369420 T1 ATE369420 T1 AT E369420T1
Authority
AT
Austria
Prior art keywords
syndrome
long
kvlqt1
disclosed
mutations
Prior art date
Application number
AT99922910T
Other languages
English (en)
Inventor
Mark T Keating
Michael C Sanguinetti
Mark E Curran
Gregory M Landes
Timothy D Connors
Timothy C Burn
Igor Splawski
Qing Cn Wang
Original Assignee
Univ Utah Res Found
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found, Genzyme Corp filed Critical Univ Utah Res Found
Application granted granted Critical
Publication of ATE369420T1 publication Critical patent/ATE369420T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT99922910T 1998-07-29 1999-05-12 Kvlqt1 - im zusammenhang mit 'long qt syndrom' ATE369420T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9447798P 1998-07-29 1998-07-29
US09/135,010 US6277978B1 (en) 1995-12-22 1998-08-17 KVLQT1—a long QT syndrome gene

Publications (1)

Publication Number Publication Date
ATE369420T1 true ATE369420T1 (de) 2007-08-15

Family

ID=26788931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922910T ATE369420T1 (de) 1998-07-29 1999-05-12 Kvlqt1 - im zusammenhang mit 'long qt syndrom'

Country Status (8)

Country Link
US (5) US6277978B1 (de)
EP (1) EP1100538B1 (de)
JP (1) JP2002521045A (de)
AT (1) ATE369420T1 (de)
AU (1) AU758048B2 (de)
CA (1) CA2336263A1 (de)
DE (1) DE69936781T2 (de)
WO (1) WO2000006199A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011139A1 (en) * 1996-09-11 1998-03-19 Oregon Health Sciences University Small and intermediate conductance, calcium-activated potassium channels and uses thereof
EP1290220B1 (de) * 2000-04-13 2007-12-19 Georgetown University Genetische diagnose zur feststellung von qt-verlängerungen als unerwünschte reaktion auf arzneimittel
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
EP1425415A2 (de) * 2001-08-20 2004-06-09 Genaissance Pharmaceuticals, Inc. Mit ionenkanalkrankheit assoziierte polymorphismen
EP1579003A2 (de) * 2002-12-21 2005-09-28 Pfizer Products Inc. Methoden und zusammensetzungen im zusammenhang mit medikament-induzierten herzrhythmusstörungen
US7537928B2 (en) * 2003-08-22 2009-05-26 Masonic Medical Research Laboratory Mutations in ion channel proteins associated with sudden cardiac death
US7833718B2 (en) * 2006-11-06 2010-11-16 Masonic Medical Research Laboratory CACNA1C nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2325820T3 (es) * 1995-12-22 2009-09-18 University Of Utah Research Foundation Gen del sindrome qt largo que codifica kvlqt1 y su asociacion con mink.
ATE211918T1 (de) 1996-10-21 2002-02-15 Morten Sloth Weidner Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium
ATE337788T1 (de) 1998-03-26 2006-09-15 Phytopharm Plc Steroidale saponine zur behandlung der alzheimerischen krankheit
AUPP797598A0 (en) 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
US6194469B1 (en) 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
US20010006686A1 (en) 1999-03-19 2001-07-05 David G. Corley Inflammatory mediation obtained from atractylodes lancea

Also Published As

Publication number Publication date
CA2336263A1 (en) 2000-02-10
EP1100538A4 (de) 2003-07-02
US6451534B1 (en) 2002-09-17
US6582913B1 (en) 2003-06-24
DE69936781D1 (de) 2007-09-20
US6277978B1 (en) 2001-08-21
JP2002521045A (ja) 2002-07-16
EP1100538A2 (de) 2001-05-23
US6420124B1 (en) 2002-07-16
US20030170708A1 (en) 2003-09-11
WO2000006199A8 (en) 2001-04-12
AU3980099A (en) 2000-02-21
US6972176B2 (en) 2005-12-06
WO2000006199A1 (en) 2000-02-10
DE69936781T2 (de) 2008-06-05
EP1100538B1 (de) 2007-08-08
AU758048B2 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
EP1100825A4 (de) Mutationen des menschlichen mink gens, die mit arrhytmie verbunden sind
Puffenberger Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania
Heath et al. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis
Burwinkel et al. Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease
Cossée et al. Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations
Gregory et al. DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1
Ono et al. Identification of a large novel imprinted gene cluster on mouse proximal chromosome 6
Gad et al. Identification of a large rearrangement of theBRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing
Stein et al. Identification of the Y chromosome in chinook salmon (Oncorhynchus tshawytscha)
FR2731014B1 (fr) Molecules d'adn, preparation et utilisation en therapie genique
EP0961833A4 (de) Hyaluronidase aus menschlichem plasma
EP1553190A3 (de) Mutationen und genomische Struktur des Herg-Gens - ein Gen des Long-QT-Syndroms
DE69936781D1 (de) Kvlqt1 - im zusammenhang mit 'long qt syndrom'
EP0973794A4 (de) Netrinrezeptoren
Ingelson et al. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E∊ 4
WO2000063441A3 (en) Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
Lovell et al. Ethiopia: between sub‐Saharan Africa and western Eurasia
Su et al. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli
Rogers et al. Linkage mapping in Papio baboons: conservation of a syntenic group of six markers on human chromosome 1
Putku et al. Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans
Nakatsuru et al. Genetic dissection of the complex pathological manifestations of collagen disease in MRL/lpr mice
Onodera et al. High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan
Koyama et al. The cell adhesion regulator (CAR) gene, TaqI and insertion/deletion polymorphisms, and regional assignment to the peritelomeric region of 16q by linkage analysis
Beutler et al. Commentary on HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors by Naveen Arya, Subrata Chakrabrati, Robert A. Hegele, Paul C. Adams
Berggren et al. MHC promoter polymorphism in grey wolves and domestic dogs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties